Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Amryt Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Dublin, Ireland Founded 2012 251-500 employees For Profit

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

Amryt Pharma on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Amryt Pharma was acquired by Chiesi Farmaceutici in 2023 for $1.25B.
Total Funding
$186.28M
Funding Rounds
3
Last Funding
Acquisitions
3
Monthly Visits
Contacts
129

About Amryt Pharma

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
AMYT
Exchange
LSE - London Stock Exchange
IPO date
Jun 22, 2012
Delisted
Apr 12, 2023

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Active products
16
IT spend
$5.06M

Company Info

Founded
2012
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
61
HQ
Dublin, Ireland
Region
European Union (EU), Europe, Middle East, and Africa (EMEA)
Exit date
Jun 22, 2012

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.4
Trend (90d)
-0.3
Last leadership hire
Jun 27, 2022

Amryt Pharma Funding Rounds

3 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–3 of 3Show
Page 1 / 1

Amryt Pharma Acquisitions

3 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Chiasma2021-05-05Amryt PharmaAcquisitionStockBiopharmaBiotechnologyTherapeuticsNeedhamUnited StatesChiasma is a biopharmaceutical company developing oral drugs2001-01-0151-100BiopharmaLife ScienceMedicalPharmaceuticalIreland251-500Delisted3chiasma.com
Aegerion Pharmaceuticals2019-03-20Amryt PharmaAcquisitionBiotechnologyHealth CareTherapeuticsCambridgeUnited StatesAegerion Pharmaceuticals engages in the development of thera2005-01-01101-250BiopharmaLife ScienceMedicalPharmaceuticalIreland251-500Delisted3www.aegerion.com
Sompharmaceuticals2016-05-13Amryt PharmaAcquisitionBiotechnologyClinical TrialsPharmaceuticalTherapeuticsEpalingesSwitzerlandSompharmaceuticals is a Swiss biopharmaceutical company.2012-01-011-10BiopharmaLife ScienceMedicalPharmaceuticalIreland251-500Delisted3sompharmaceuticals.com
1–3 of 3Show
Page 1 / 1

Amryt Pharma Key People

CEO and Founder
CFO & CCO
Chief Medical officer & Vice President, Head of Development
Non-Executive Chairman
129
professional contacts at Amryt Pharma
Contact execs at Amryt Pharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Amryt Pharma

Loading news…

FAQs about Amryt Pharma

People who checked this page also checked these

Browse the full Acquirezy directory.